Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3ES0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,950
Award facts
- Contract value 100% obligated
- $31,950.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract valued at $31,950.34, with an ultimate completion date of December 16, 2025. This non-set-aside award was competitively awarded and represents a single delivery order fulfillment of this diabetes medication to support federal medical procurement needs. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical supply chains, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, with delivery orders consistently structured under firm fixed-price arrangements. This award reflects the ongoing demand for specialty and brand-name pharmaceutical products within the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F3ES0?
SPE2DR26F3ES0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F3ES0 worth?
The government has obligated $31,950 on SPE2DR26F3ES0.
Is contract SPE2DR26F3ES0 an order under another contract?
Yes. SPE2DR26F3ES0 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3ES0 competed?
The extent of competition for SPE2DR26F3ES0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award